JP2010529212A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529212A5
JP2010529212A5 JP2009551999A JP2009551999A JP2010529212A5 JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5 JP 2009551999 A JP2009551999 A JP 2009551999A JP 2009551999 A JP2009551999 A JP 2009551999A JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5
Authority
JP
Japan
Prior art keywords
poz
compound
group
functional group
active functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009551999A
Other languages
English (en)
Japanese (ja)
Other versions
JP5615558B2 (ja
JP2010529212A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/002626 external-priority patent/WO2008106186A2/en
Publication of JP2010529212A publication Critical patent/JP2010529212A/ja
Publication of JP2010529212A5 publication Critical patent/JP2010529212A5/ja
Application granted granted Critical
Publication of JP5615558B2 publication Critical patent/JP5615558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009551999A 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物 Active JP5615558B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89221207P 2007-02-28 2007-02-28
US60/892,212 2007-02-28
PCT/US2008/002626 WO2008106186A2 (en) 2007-02-28 2008-02-28 Activated polyoxazolines and compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2010529212A JP2010529212A (ja) 2010-08-26
JP2010529212A5 true JP2010529212A5 (OSRAM) 2011-04-07
JP5615558B2 JP5615558B2 (ja) 2014-10-29

Family

ID=39721806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551999A Active JP5615558B2 (ja) 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物

Country Status (6)

Country Link
US (1) US7943141B2 (OSRAM)
EP (1) EP2134181A4 (OSRAM)
JP (1) JP5615558B2 (OSRAM)
KR (2) KR101508617B1 (OSRAM)
CN (2) CN106046370A (OSRAM)
WO (1) WO2008106186A2 (OSRAM)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088884B2 (en) * 2007-09-27 2012-01-03 Serina Therapeutics, Inc. Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
US8101706B2 (en) 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
US8110651B2 (en) 2008-01-11 2012-02-07 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
CN102159250B (zh) 2008-08-11 2014-08-06 尼克塔治疗公司 多臂的聚合烷酸酯偶联物
US20110318322A1 (en) 2009-01-12 2011-12-29 Nektar Therapeutics Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
KR20200070407A (ko) 2010-11-12 2020-06-17 넥타르 테라퓨틱스 Il-2 부분 및 중합체의 접합체
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
WO2013020005A2 (en) * 2011-08-03 2013-02-07 Anp Technologies, Inc. Oxazoline polymer compositions and use thereof
WO2013020079A2 (en) 2011-08-04 2013-02-07 Nektar Therapeutics Conjugates of an il-11 moiety and a polymer
US8383093B1 (en) 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
US9416228B2 (en) * 2012-03-16 2016-08-16 Bender Analytical Holding B.V. Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline
EP3660033B9 (en) 2012-11-15 2022-06-22 Apellis Pharmaceuticals, Inc. Long-acting compstatin analogs and related compositions and methods
CN103897181B (zh) * 2012-12-27 2017-02-08 张昊 聚合物、其制备方法和应用
US9624191B2 (en) 2014-03-24 2017-04-18 International Business Machines Corporation Cyclic carbonate monomers and ring opened polycarbonates therefrom
US9215876B2 (en) 2014-03-24 2015-12-22 International Business Machines Corporation 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom
GB201405391D0 (en) * 2014-03-26 2014-05-07 Applied Biomimetic As Novel polymers and process for making membranes
MA39711A (fr) 2014-04-03 2015-10-08 Nektar Therapeutics Conjugués d'une fraction d'il-15 et d'un polymère
BR112017000911B1 (pt) 2014-07-18 2023-04-11 Universiteit Gent Método para preparação de polímeros uniformes de iminoéter cíclico tendo massa molar elevada
WO2016019340A1 (en) * 2014-07-31 2016-02-04 Serina Therapeutics, Inc. Polyoxazoline antibody drug conjugates
BR112017006943B1 (pt) 2014-10-06 2020-12-01 Gatt Technologies B.V produto hemostático poroso adesivo de tecido
HK1259307A1 (zh) 2015-10-07 2019-11-29 阿佩利斯制药有限公司 给药方案
MA47290A (fr) 2015-10-08 2019-11-27 Nektar Therapeutics Combinaison d'un agoniste sélectif de l'il-2rbeta et d'un agoniste de l'il-15 à action prolongée
AU2018249627B2 (en) 2017-04-07 2025-04-03 Apellis Pharmaceuticals, Inc. Dosing regimens and related compositions and methods
IL270634B2 (en) 2017-05-15 2025-06-01 Nektar Therapeutics Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
IL271903B2 (en) 2017-07-11 2025-04-01 Synthorx Inc Combination of unnatural nucleotides and methods therefor
SG11202000939PA (en) 2017-08-03 2020-02-27 Synthorx Inc Cytokine conjugates for the treatment of proliferative and infectious diseases
EP3502217B1 (en) * 2017-11-29 2020-05-27 Infineum International Limited Lubricating oil compositions
US10822569B2 (en) 2018-02-15 2020-11-03 Afton Chemical Corporation Grafted polymer with soot handling properties
WO2019165453A1 (en) 2018-02-26 2019-08-29 Synthorx, Inc. Il-15 conjugates and uses thereof
US10851324B2 (en) 2018-02-27 2020-12-01 Afton Chemical Corporation Grafted polymer with soot handling properties
CN110865055B (zh) * 2018-08-27 2022-10-25 香港科技大学 无金属偶联方法、偶联物及其应用
US10899989B2 (en) 2018-10-15 2021-01-26 Afton Chemical Corporation Amino acid grafted polymer with soot handling properties
EP3876973B1 (en) 2018-11-08 2025-10-22 Synthorx, Inc. Interleukin 10 conjugates and uses thereof
US11046908B2 (en) 2019-01-11 2021-06-29 Afton Chemical Corporation Oxazoline modified dispersants
EP3923974A4 (en) 2019-02-06 2023-02-08 Synthorx, Inc. IL-2 CONJUGATES AND METHODS OF USE THEREOF
US12485181B2 (en) 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
BR112022001554A2 (pt) * 2019-07-30 2022-03-22 Gatt Tech B V Copolímero de polioxazolina, uso do copolímero, produto médico biocompatível e processo de preparação de copolímeros
TW202124385A (zh) 2019-09-10 2021-07-01 美商欣爍克斯公司 治療自體免疫疾病之il-2接合物及使用方法
TW202203973A (zh) 2020-04-22 2022-02-01 美商默沙東藥廠 對介白素-2受體βγc二聚體具偏性且結合至非肽、水溶性聚合物之人類介白素-2結合物
EP4291242A4 (en) 2021-02-09 2025-11-26 Serina Therapeutics Al Inc POLYOXAZOLINE-LIPID CONJUGATES AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
MX2024002725A (es) 2021-09-03 2024-03-15 CureVac SE Nuevas nanoparticulas lipidicas para la administracion de acidos nucleicos que comprenden fosfatidilserina.
AU2022336209B2 (en) 2021-09-03 2025-10-16 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
US20250027108A1 (en) 2021-10-29 2025-01-23 CureVac SE Improved circular rna for expressing therapeutic proteins
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
CA3248399A1 (en) 2022-01-31 2023-08-03 Genevant Sciences Gmbh POLY(ALKYLOXAZOLINE)-LIPIDS CONJUGATES AND LIPID PARTICLES CONTAINING THEM
CN114685784B (zh) * 2022-04-26 2023-09-15 北京清科胜因生物科技有限公司 一种用于核酸递送的聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
CN114940756B (zh) * 2022-06-02 2023-11-07 北京清科胜因生物科技有限公司 一种聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
WO2024098023A2 (en) 2022-11-04 2024-05-10 Sutro Biopharma, Inc. Interferon alpha polypeptides and conjugates
WO2024184500A1 (en) 2023-03-08 2024-09-12 CureVac SE Novel lipid nanoparticle formulations for delivery of nucleic acids
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
EP4656669A1 (en) 2024-05-28 2025-12-03 Arkema France Fluorinated copolymers based on an oligo(2-oxazoline) macromonomer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2643403B2 (ja) * 1989-01-10 1997-08-20 花王株式会社 ポリ(n―アシルアルキレンイミン)系共重合体及びその用途
US5635571A (en) * 1995-06-30 1997-06-03 Cornell Research Foundation, Inc. Polymerizable macromonomers and polymers prepared therefrom
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
AP1763A (en) * 2001-05-21 2007-08-02 Nektar Therapeutics Pulmonary administration of chemically modified insulin
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
US7056500B2 (en) * 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
AU2003205384A1 (en) * 2002-02-01 2003-09-02 Intradigm Corporation Polymers for delivering peptides and small molecules in vivo
CN101132812A (zh) * 2004-03-15 2008-02-27 阿拉巴马耐科塔医药公司 Hiv进入抑制剂的聚合物基组合物和结合物
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
JP5081623B2 (ja) * 2005-09-01 2012-11-28 独立行政法人科学技術振興機構 オキサゾリンのランダム共重合体

Similar Documents

Publication Publication Date Title
JP2010529212A5 (OSRAM)
JP5514736B2 (ja) ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物
JP2016525466A5 (OSRAM)
JP2010535870A5 (OSRAM)
JP2004535485A5 (OSRAM)
JP2006520339A5 (OSRAM)
WO2012086762A1 (ja) アミノ基含有ホスホリルコリン化合物及びその製造方法
JP2009501198A5 (OSRAM)
JP2007077384A5 (OSRAM)
JPWO2021049504A5 (OSRAM)
JP2018507273A5 (OSRAM)
JP2010534246A5 (OSRAM)
JP2008095060A5 (OSRAM)
JP2010540488A5 (OSRAM)
JP2006225632A5 (OSRAM)
ES3022732T3 (en) Azide-functionalized copolymers
JP2008222908A5 (OSRAM)
JP2006524231A5 (OSRAM)
JP5853855B2 (ja) カルボキシル基含有ホスホリルコリン化合物及びその製造方法
EP1363878B1 (en) Process for preparing sulfamoyl-substituted phenethylamine derivatives
JP2017513885A5 (OSRAM)
JPWO2022215652A5 (OSRAM)
JP2013544876A5 (OSRAM)
JP2007154091A5 (OSRAM)
JP2003034704A5 (OSRAM)